{"text": "NTRK fusions occur in NSCLCs across genders, ages, smoking histories, and histologies. Given the potent clinical activity of TRK inhibitors, we advocate that all NSCLCs be screened for NTRK fusions using a multiplexed NGS-based fusion assay.", "denotations": [{"id": "T1", "obj": "disease", "span": {"begin": 22, "end": 28}}, {"id": "T2", "obj": "disease", "span": {"begin": 74, "end": 85}}]}
